IL6 and colitis: To investigate whether neutralising IL-6 or sIL-6Rα affects CAC, we injected anti-IL-6 antibody or the designer cytokine soluble GP130 (sGP130Fc) before the colitis phase at day 3 of the 1.5% AOM/DSS protocol in lean and obese C57BL/6 mice.